BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/PLK2/Compounds

Compounds That Target PLK2

polo like kinase 2 · 13 compounds in BiohacksAI corpus

PLK2 (polo like kinase 2) is a biological target with 13 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into PLK2 modulation for therapeutic and biohacking applications.

View PLK2 target page →UniProt: Q9NYY3 ↗
Most Studied Compounds for PLK2
1
Wortmannin
300+
studies
All 13 Compounds — Ranked by Evidence
1
Ruxolitinib
4.23
confidence
2
Bosutinib
4.08
confidence
3
Bi 2536
4.01
confidence
4
Tae 684
3.43
confidence
5
Fedratinib
3.40
confidence
6
Dovitinib
3.09
confidence
7
Lestaurtinib
3.04
confidence
8
Volasertib
2.94
confidence
9
Thymoquinone
2.89
confidence
10
R 406
2.83
confidence
11
Pha 665752
2.71
confidence
12
Gsk 461364
2.40
confidence
13
Wortmannin
300+
studies
1.10
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for PLK2 (polo like kinase 2). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: PLK2 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.